A community of bold leaders. A commitment to a world without breast cancer.
Nominate an AmbassadorSusan G. Komen® is the world's leading nonprofit breast cancer organization, working toward a future where no one dies from breast cancer. Through VIPink, professional and community leaders across the nation unite to raise critical funds to help build a world without breast cancer through research, community, care and action.
Through early detection and effective treatments, we've helped reduce the breast cancer mortality rate in the U.S. by 44% since 1989.
We've invested nearly $1.1 billion in research, leading to new ways to prevent, diagnose and better treat breast cancer.
We've invested nearly $2.5 billion in advocacy, community programs, education and patient support services, ensuring people are educated about breast cancer and have access to the care they need.
But we still have work to do.
To support an ambassador's fundraising efforts, please search for them below.
If you know of a passionate changemaker who is committed to a world without breast cancer, nominate them to become a VIPink Ambassador!
Nominate an AmbassadorKomen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information.
Guided by world renowned experts, we evaluate and invest in science and technology that will provide the greatest benefit to patients.
We serve as a trusted breast health care guide by providing evidence- based education, personalized support and connection to timely, high-quality care.
We mobilize people to advocate for policies that protect patients, prioritize research and create lasting systemic changes to improve outcomes for all.
We unite communities that are bonded by a common interest and come together to deliver a greater impact in ending breast cancer.